GILD or ABBV: Which Is Expected to Report Faster Revenue Growth?
GILD or ABBV: Which Is a Better Biotech Pick This Month?(Continued from Prior Part)Revenue projections for 2019In its fourth-quarter earnings presentation, Gilead Sciences (GILD) guided for product sales in the range of $21.3 billion–$21.8 billion